Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$57.18

0.47 (0.83%)

18:23
03/01/17
03/01
18:23
03/01/17
18:23

Bristol-Myers to present immuno-oncology therapy data at AACR 2017

Bristol-Myers Squibb announced that new clinical data will be presented at the American Association for Cancer Research Annual Meeting 2017 in Washington, D.C., from April 1-5. Research to be presented represents the company's ongoing commitment to investigating long-term survival and safety data in advanced cancers, and to exploring the interaction between biomarkers and Immuno-Oncology therapy across multiple tumor types. Results will be disclosed for Opdivo, as a single-agent and in combination with Yervoy, as well as an investigational, optimized, once-daily IDO1 inhibitor alone or in combination with Opdivo. IDO is part of Bristol-Myers Squibb's robust early clinical development pipeline and one of 21 oncology compounds in clinical study. Bristol-Myers Squibb will also share data generated as part of the International Immuno-Oncology Network, a global peer-to-peer collaboration with academia established in 2012 and focused on advancing the science of I-O through a series of preclinical, translational and biology-focused research objectives. "At Bristol-Myers Squibb, we are committed to translational research as we advance the development of next-generation Immuno-Oncology therapies and conduct biomarker research that will help us determine which patients are most likely to benefit from our treatments," said Fouad Namouni, M.D., head of development, Oncology, Bristol-Myers Squibb. "In all of our research efforts, we are driven by our overarching goal of changing the way patients live with cancer."

  • 02

    Mar

  • 06

    Mar

  • 17

    Mar

  • 01

    Apr

BMY Bristol-Myers
$57.18

0.47 (0.83%)

01/27/17
DBAB
01/27/17
NO CHANGE
Target $42
DBAB
Hold
Bristol-Myers price target lowered to $42 from $48 at Deutsche Bank
Deutsche Bank analyst Gregg Gilbert lowered his price target for Bristol-Myers Squibb to $42 citing Opdivo competitive pressures and currency. The analyst expects stock appreciation "will be challenging" and keeps a Hold rating on the shares following the company's Q4 results.
01/30/17
FBCO
01/30/17
NO CHANGE
Target $52
FBCO
Neutral
Bristol-Myers price target lowered to $52 from $61 at Credit Suisse
Credit Suisse analyst Vamil Divan lowered his price target for Bristol-Myers to $52 from $61 following Q4 results. Given the recent update that the company will not pursue an accelerated pathway for the Opdivo+Yervoy combo in first-line non-small cell lung cancer, the analyst does not see many fundamental reasons for upside to Bristol-Myers in the coming months. He reiterates a Neutral rating on the shares.
02/01/17
GSCO
02/01/17
NO CHANGE
GSCO
Bristol-Myers estimates trimmed for Sprycel loss at Goldman
Goldman reduced Bristol-Myers earnings estimates by 4c-7c for 2017-2021 to reflect the lost of the Sprycel appeal in the EU. The firm continues to rate Bristol-Myers a Buy.
02/15/17
DBAB
02/15/17
NO CHANGE
DBAB
Deutsche not seeing Pfizer buying Bristol-Myers at this time
Following yesterday's speculation of a potential deal, Deutsche Bank analyst Gregg Gilbert said he would be surprised to see Pfizer (PFE) make a move on Bristol-Myers Squibb (BMY) at this stage. Such an acquisition "would represent a very large and concentrated opportunity/risk on immuno-oncology, an area fraught with near-term uncertainty," Gilbert told investors last night in a research note. He believes that if Pfizer were to use $90B for a deal, it would prefer to acquire a more diverse set of value drivers. The analyst keeps a Hold rating on Bristol and Buy rating on Pfizer. Bristol shares rose 3% yesterday to $53.71 amid speculation of a potential takeover. The conjecture had Roche (RHHBY), Novartis (NVS) and Pfizer potentially looking into a bid for Bristol.

TODAY'S FREE FLY STORIES

NTAP

NetApp

$42.41

0.44 (1.05%)

17:48
08/16/17
08/16
17:48
08/16/17
17:48
Hot Stocks
NetApp says headwind for services revenue to decrease in coming quarters »

Comments from Q1 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

ACHN

Achillion

$4.88

-0.12 (-2.40%)

17:45
08/16/17
08/16
17:45
08/16/17
17:45
Conference/Events
Achillion management to meet with William Blair »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BCOR

Blucora

$23.35

0.1 (0.43%)

, BBOX

Black Box

$3.75

-0.25 (-6.25%)

17:35
08/16/17
08/16
17:35
08/16/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Blucora (BCOR),…

BCOR

Blucora

$23.35

0.1 (0.43%)

BBOX

Black Box

$3.75

-0.25 (-6.25%)

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

LB

L Brands

$39.55

0.5 (1.28%)

VIPS

Vipshop

$11.10

-0.07 (-0.63%)

SPTN

SpartanNash

$25.96

0.07 (0.27%)

SNPS

Synopsys

$79.09

0.86 (1.10%)

CSCO

Cisco

$32.34

0.25 (0.78%)

NTAP

NetApp

$42.41

0.44 (1.05%)

LAKE

Lakeland Industries

$15.65

-0.25 (-1.57%)

GCP

GCP Applied Technologies

$28.75

0.1 (0.35%)

FNGN

Financial Engines

$34.35

-0.1 (-0.29%)

ACHC

Acadia

$51.68

-0.33 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 29

    Aug

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 30

    Nov

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

, WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

17:26
08/16/17
08/16
17:26
08/16/17
17:26
Upgrade
Andeavor Logistics, Western Refining Logistics rating change  »

Andeavor Logistics…

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$200.61

1.12 (0.56%)

17:22
08/16/17
08/16
17:22
08/16/17
17:22
Hot Stocks
General Dynamics awarded $115.3M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

BLVD

Boulevard Acquisition

$10.04

-0.01 (-0.10%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Hot Stocks
Breaking Hot Stocks news story on Boulevard Acquisition »

Glazer Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBH

First Mid-Illinois Bancshares

$34.85

-0.33 (-0.94%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Syndicate
First Mid-Illinois Bancshares files to sell $20M of common stock 'at-the-market' »

First Mid-Illinois…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

NCOM

National Commerce

$39.55

0.1 (0.25%)

17:16
08/16/17
08/16
17:16
08/16/17
17:16
Hot Stocks
National Commerce, FirstAtlantic Financial sign definitive merger agreement »

National Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AMGN

Amgen

$171.39

1.35 (0.79%)

17:13
08/16/17
08/16
17:13
08/16/17
17:13
Hot Stocks
Amgen: NEJM publishes results from Repatha cognitive function trial »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

  • 08

    Sep

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 17

    May

WLK

Westlake Chemical

$71.03

0.84 (1.20%)

17:13
08/16/17
08/16
17:13
08/16/17
17:13
Hot Stocks
Westlake Chemical CFO Mark Bender sells 13,794 shares of company stock »

Mark Bender, Westlake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBOX

Black Box

$3.75

-0.25 (-6.25%)

17:10
08/16/17
08/16
17:10
08/16/17
17:10
Hot Stocks
Black Box director John Heller buys 10,000 shares of company stock »

Black Box director John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOR

Blucora

$23.35

0.1 (0.43%)

17:07
08/16/17
08/16
17:07
08/16/17
17:07
Hot Stocks
Blucora director retires from board effective August 10 »

Elizabeth J. Huebner, who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

17:06
08/16/17
08/16
17:06
08/16/17
17:06
Earnings
Briggs & Stratton sees FY18 EPS $1.31-$1.48, consensus $1.38 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

17:05
08/16/17
08/16
17:05
08/16/17
17:05
Earnings
Briggs & Stratton reports Q4 EPS 46c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.34

0.25 (0.78%)

17:02
08/16/17
08/16
17:02
08/16/17
17:02
Hot Stocks
Breaking Hot Stocks news story on Cisco »

Cisco says order booking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

MED

Medifast

$51.63

-0.4 (-0.77%)

16:58
08/16/17
08/16
16:58
08/16/17
16:58
Initiation
Medifast initiated  »

Medifast initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$12.11

-0.1 (-0.82%)

16:57
08/16/17
08/16
16:57
08/16/17
16:57
Hot Stocks
Daseke completes term loan amendment to support growth strategy »

Daseke announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

QEP

QEP Resources

$7.09

-0.2 (-2.74%)

16:55
08/16/17
08/16
16:55
08/16/17
16:55
Hot Stocks
Breaking Hot Stocks news story on QEP Resources »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.34

0.25 (0.78%)

16:50
08/16/17
08/16
16:50
08/16/17
16:50
Hot Stocks
Cisco to realign reporting into 5 distinct categories starting in 1Q18 »

Says innovation "as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

LB

L Brands

$39.55

0.5 (1.28%)

16:48
08/16/17
08/16
16:48
08/16/17
16:48
Hot Stocks
L Brands sees FY17 SSS down low to mid-single digits »

Sees FY17 SSS excluding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

LB

L Brands

$39.55

0.5 (1.28%)

16:46
08/16/17
08/16
16:46
08/16/17
16:46
Hot Stocks
L Brands sees Q3 SSS flat to down low-single digits »

Sees Q3 SSS excluding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

LGL

LGL Group

$4.31

0.0012 (0.03%)

16:40
08/16/17
08/16
16:40
08/16/17
16:40
Hot Stocks
LGL Group announces terms for rights offering »

The LGL Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLST

Netlist

$0.84

-0.06 (-6.67%)

16:37
08/16/17
08/16
16:37
08/16/17
16:37
Syndicate
Netlist files to sell common stock, no amount given »

Craig-Hallum Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRAH

PRA Health

$75.16

-0.54 (-0.71%)

16:34
08/16/17
08/16
16:34
08/16/17
16:34
Initiation
PRA Health initiated  »

PRA Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$39.55

0.5 (1.28%)

16:34
08/16/17
08/16
16:34
08/16/17
16:34
Hot Stocks
L Brands reports Q2 L Brands company SSS down 8% »

Reports Q2 L Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.